Suchergebnisse - "Brufsky, Adam"

PubPharm (14)

1

Real-World Treatment Patterns and Outcomes of Palbociclib Plus an Aromatase Inhibitor for Metastatic Breast Cancer : Flatiron Database Analysis

enthalten in: Clinical breast cancer | 2022

von Patt, D. | Liu, X. | Li, B. | +3

2

Treatment Patterns and Outcomes Associated With Palbociclib Plus Letrozole for Postmenopausal Women With HR+/HER2- Advanced Breast Cancer Enrolled in an Expanded Access Program

enthalten in: Clinical breast cancer | 2019

von Brufsky, A. | Mitra, D. | Davis, K. | +4

3

Features Associated With Long-Term Survival in Patients With Metastatic Breast Cancer

enthalten in: Clinical breast cancer | 2019

von Klar, N. | Rosenzweig, M. | Diergaarde, B. | +1

CommentIn: Clin Breast Cancer. 2019 Jun;19(3):e406. - PMID 30926202

4

Metastatic Breast Cancer Patient With Activating HER2 Exon 20 Insertion Mutation With Response to Poziotinib : Case Report of Compassionate Drug Use

enthalten in: Clinical breast cancer | 2019

von Pandey, A. | Brufsky, A.

5

Expanded-Access Study of Palbociclib in Combination With Letrozole for Treatment of Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

enthalten in: Clinical breast cancer | 2018

von Stearns, V. | Brufsky, A. | Verma, S. | +4

6

Ramucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy : A Multicenter, Randomized, Phase II Study

enthalten in: Clinical breast cancer | 2016

von Yardley, D. | Reeves, J. | Dees, E. | +17

7

A randomized phase II study of paclitaxel and bevacizumab with and without gemcitabine as first-line treatment for metastatic breast cancer

enthalten in: Clinical breast cancer | 2011

von Brufsky, A. | Hoelzer, K. | Beck, T. | +16

8

Sunitinib plus paclitaxel versus bevacizumab plus paclitaxel for first-line treatment of patients with advanced breast cancer : a phase III, randomized, open-label trial

enthalten in: Clinical breast cancer | 2011

von Robert, N. | Saleh, M. | Paul, D. | +13

ErratumIn: Clin Breast Cancer. 2011 Aug;11(4):273

9

Phase II trial of weekly nanoparticle albumin-bound paclitaxel with carboplatin and trastuzumab as first-line therapy for women with HER2-overexpressing metastatic breast cancer

enthalten in: Clinical breast cancer | 2010

von Conlin, A. | Seidman, A. | Bach, A. | +9

10

Zoledronic acid effectively prevents aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole : Z-FAST study 36-month follow-up results

enthalten in: Clinical breast cancer | 2009

von Brufsky, A. | Bosserman, L. | Caradonna, R. | +7